Document Detail

Hypofibrinolysis is a risk factor for arterial thrombosis at young age.
MedLine Citation:
PMID:  19183334     Owner:  NLM     Status:  MEDLINE    
The relationship between defective fibrinolysis and arterial thrombosis is uncertain. The evaluation of the plasma fibrinolytic potential might provide stronger evidence linking fibrinolysis to arterial thrombosis than the evaluation of the individual fibrinolytic factors. We determined the plasma fibrinolytic potential of 335 young survivors of a first arterial thrombosis, including coronary artery disease (n = 198), ischaemic stroke (n = 103) and peripheral artery disease (n = 34), enrolled in a population-based case-control study and of 330 healthy individuals. Patients had significantly higher clot lysis times (CLTs) than the controls. Odds ratios (ORs) were calculated as a measure of relative risk. The OR for arterial thrombosis was determined in these subjects who had a CLT above the 60th, 70th, 80th, 90th and 95th percentiles of the values found in the control subjects. We found a progressive increase in risk of arterial thrombosis in subjects with hypofibrinolysis (OR: 1.7, 2.0, 2.3, 2.3 and 2.9, respectively). Relative risk estimates obtained in the whole group were comparable those obtained in the event-subgroups. In conclusion, a low plasma fibrinolytic potential, found in 10% of the population, increases the relative risk of arterial thrombosis twofold. This points to an important contribution of hypofibrinolysis to the burden of arterial thrombosis.
Ana H C Guimarães; Emile L E de Bruijne; Ton Lisman; Diederik W J Dippel; Jaap W Deckers; Don Poldermans; Dingeman C Rijken; Frank W G Leebeek
Related Documents :
19717384 - Arterial thrombosis with immunomodulatory derivatives in the treatment of multiple myel...
18204284 - Acquired angioedema associated with primary antiphospholipid syndrome in a patient with...
665314 - A family with thromboembolic disease associated with deficient fibrinolytic activity in...
9851814 - Some effects of prophylactic aspirins and heparins on concurrent arterial and venous th...
8624774 - Apolipoproteins b, (a), and e accumulate in the morphologically early lesion of 'degene...
11068214 - Extensible expanded polytetrafluoroethylene vascular grafts for aortoiliac and aortofem...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-01-30
Journal Detail:
Title:  British journal of haematology     Volume:  145     ISSN:  1365-2141     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-03-18     Completed Date:  2009-06-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  England    
Other Details:
Languages:  eng     Pagination:  115-20     Citation Subset:  IM    
Department of Haematology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Body Mass Index
Brain Ischemia / blood,  physiopathology
Case-Control Studies
Coronary Artery Disease / blood,  physiopathology
Fibrinolysis / drug effects,  physiology*
Middle Aged
Odds Ratio
Peripheral Vascular Diseases / blood,  physiopathology
Thrombosis / blood*,  physiopathology
Tissue Plasminogen Activator / diagnostic use
Young Adult
Reg. No./Substance:
EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reduced neorectal capacitance is a more important factor for impaired defecatory function after rect...
Next Document:  Comparative studies of brain evolution: a critical insight from the Chiroptera.